Pathogenic KCNA1 variants have been reported in patients with EA1 characterized by constant myokymia, episodic ataxia, and occasional epilepsy but normal cognition, and were unexpected in patients with severe epilepsy and significant cognitive impairment (Rogers et al., 2018). This evidence concerns the gene KCNA1 and episodic ataxia type 1.